Published recall report · See noticeUpdated · 1 yr 8 mo ago
Astellas Pharma US Inc. recall: Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.
Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.
- Producer
- Astellas Pharma US Inc.
- Brand
- PROGRAF
Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.
- Dates on pack
- Lot# 0E3353D, Exp 03/31/2026
0304690607731
0304690657736
0304691230501
0304691330508
0304690617730
0304693016011
More detail
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.